top of page

Episode 6 – Exploring FDA Final Guidance on PCCPs
Bridging Consulting releases Episode 6 of "Alexis and Ethan Explain It All," exploring FDA's final PCCP guidance for AI-enabled devices.
Yu Zhao
2024年12月3日讀畢需時 1 分鐘
1 次查看
0 則留言

Bridging Consulting Launches Podcast Series on Digital Health and FDA Regulations
Bridging Consulting launches "Alexis and Ethan Explain It All" podcast, exploring FDA Digital Health, Generative AI, and healthcare innovati
Yu Zhao
2024年11月3日讀畢需時 1 分鐘
4 次查看
0 則留言


Data-Driven Trends In Predetermined Change Control Plans
Data-driven trends show increased FDA authorization of PCCPs, enhancing SaMD compliance and postmarket change controls.
Yu Zhao
2024年7月12日讀畢需時 9 分鐘
2 次查看
0 則留言


Yu Zhao Joins Orthogonal Panel on Accelerating AI Algorithm Updates with PCCP
Yu Zhao joined a panel hosted by Orthogonal discussing how PCCP accelerates AI algorithm updates, FDA policies, and best practices.
Yu Zhao
2024年6月28日讀畢需時 1 分鐘
3 次查看
0 則留言


Part III: SaMD PCCP Implementation Beyond AIML: Considerations & Challenges
This article provides tips and practical considerations for PCCP implementation.
Yu Zhao
2023年10月13日讀畢需時 6 分鐘
4 次查看
0 則留言


Part II: Deciphering New US Laws Around Predetermined Change Control Plan
This article deciphers the new U.S. laws around Predetermined Change Control Plans (PCCP).
Yu Zhao
2023年10月10日讀畢需時 11 分鐘
2 次查看
0 則留言


Part I: Medical Device Postmarket Change Controls and FDA 510(k) Software Modification Guidance
FDA's guidance on postmarket change controls for 510(k) software modifications ensures SaMD changes maintain safety and compliance.
Yu Zhao
2023年10月4日讀畢需時 5 分鐘
3 次查看
0 則留言

Yu Zhao Co-Hosts Panel on Global AI-Based Medical Device Regulations at MedCon 2022
Yu Zhao co-hosted a panel on AI-based medical device regulations at MedCon 2022, discussing EU AI Act and U.S. FDA framework for SaMD.
Yu Zhao
2022年5月3日讀畢需時 1 分鐘
1 次查看
0 則留言
bottom of page